Welcome to Research Canter

At Surat Raktadan Kendra & Research Centre, we are dedicated to advancing knowledge and fostering innovation through cutting-edge academic research. Our institute is committed to excellence in research across a wide range of disciplines, providing a vibrant intellectual environment for scholars, students, and researchers alike.As a premier academic research institute, we strive to create an environment that promotes collaboration, critical thinking, and interdisciplinary exploration. Our Research and Development (R&D) division serves as the nucleus of our creative endeavours, where ideas flourish, and breakthroughs become reality.

Research Areas

At Raktadan Kendra & Research Centre, our research encompasses a diverse array of disciplines, including but not limited to :

Science and Technology

Exploring the frontiers of science and technology to push the boundaries of human knowledge and innovation.

Biotechnology and Life Sciences

Exploring the intricacies of biological systems, from molecular mechanisms to ecosystem dynamics, to develop innovative solutions for healthcare, agriculture, and environmental sustainability.

Health and Medicine

Conducting research to improve healthcare outcomes, advance medical knowledge, and enhance public health.

Basic Stem Cell Biology

Investigating the fundamental properties of stem cells, including their self-renewal capacity, differentiation potential, and molecular regulation, to better understand their biological mechanisms and therapeutic applications.

Regenerative Medicine

Developing novel stem cell-based therapies and tissue engineering approaches to regenerate damaged or diseased tissues and organs, with the aim of restoring function and improving patient outcomes in areas such as neurology, cardiology, orthopaedics, and more.

Stem Cell Therapy Clinical Trials

Translating stem cell research discoveries into clinical applications through the conduct of rigorous clinical trials, evaluating the safety and efficacy of stem cell-based therapies in patients with various medical conditions.

Transfusion Medicine

It includes issues of blood donation, immunohematology and other laboratory testing for transfusion-transmitted diseases, management and monitoring of clinical transfusion practices, patient blood management, therapeutic apheresis and coagulation.

Artificial Intelligence and Data Science

Leveraging the power of machine learning, data analytics, and computational modelling to tackle complex problems in areas such as healthcare, finance, transportation, and beyond.

Our Services

Platelet-Rich Plasma (PRP)

Our PRP technology harnesses the healing power of platelets to accelerate tissue repair and regeneration. Derived from the patient's own blood, PRP is rich in growth factors and cytokines that promote healing and tissue regeneration in orthopedic, dermatologic, and aesthetic applications. Our advanced PRP formulations are optimized for maximum efficacy and safety, offering clinicians and patients cutting-edge solutions for tissue repair and rejuvenation.PRP injections are used for a range of conditions, from musculoskeletal pain and injuries to cosmetic procedures.Side effects of PRP injections are very limited because the injections are created from your own blood, and your body should not reject them or react in any negative way.

Platelet-Rich Fibrin (PRF)

PRF is a next-generation autologous biomaterial derived from the patient's blood, enriched with platelets, fibrin, and leukocytes. Our PRF formulations are engineered to stimulate tissue regeneration and promote wound healing in various medical and dental applications. With superior handling properties and biocompatibility, PRF offers clinicians a versatile tool for enhancing surgical outcomes and accelerating tissue repair.

Mesenchymal Stem Cells (MSCs)

MSCs are multipotent cells with the remarkable ability to differentiate into various cell types, making them promising candidates for regenerative medicine and tissue engineering. Our MSC-based products harness the regenerative potential of these cells to treat a wide range of medical conditions, including orthopedic injuries, autoimmune disorders, and degenerative diseases. Through advanced cell isolation and expansion techniques, we deliver high-quality MSC products that meet the highest standards of safety and efficacy.

Bone Marrow Concentrate (BMC)

BMC is a concentrated source of autologous stem cells, growth factors, and cytokines derived from the patient's bone marrow. Our BMC formulations are optimized to promote tissue repair and regeneration in orthopedic and musculoskeletal conditions, such as osteoarthritis, sports injuries, and spinal disorders. With proven efficacy and minimal invasiveness, BMC offers patients a natural alternative to traditional treatments, restoring function and improving quality of life.

Moreover in the whole world, around 8% to 12% of couples tend to get affected by the curse of infertility. And introduction of Bone Marrow Stem Cell in IVF has taken the world by storm. It is seemingly much more effective than the traditional procedure, as it can create undifferentiated cells without any complication.

NEW DEVELOPMENT

Our institute is home to a distinguished faculty of stem cell biologists, developmental biologists, bioengineers, clinicians, and other experts who are leaders in their respective fields. Our faculty members are dedicated to conducting innovative research, mentoring the next generation of scientists, and translating research findings into clinical practice. Meet some of our esteemed faculty members:

  • 1. Autologous Intraarticular Platelet-rich Plasma (PRP) Injection Therapy for the Treatment for Knee Osteoarthritis, Treatment of thin endometrium and Hair Regeneration etc
  • 2. By Molecular technique Verification of Surface Markers Expression and Pluripotency of Wharton’s jelly derived Mesenchymal Stem Cells (WJ-MSCs). Cell and Tissue Biology, 2021.
  • 3. Platelet-Rich Fibrin (PRF): PRF can be used to promote wound healing, bone regeneration, graft stabilization, wound sealing, and hemostasis.
  • 4. Long-Term in vitro Multiplied Mesenchymal Stem Cells prior to Their Use in Clinical Administration. Cells Tissues Organs. 2021 Sep 14:1-11.
  • 5. Vincristine a Non-Colcemid Mitosis Arresting Agent for Karyotyping of Peripheral Blood Lymphocyte Culture.(In process for patent filing)
  • 6. A Multiplex ARMA-PCR Approach to the Detection of common β-Globin Gene Mutation. Anal Biochem. 2017 Nov 15;537:93-98. doi: 10.1016/j.ab.2017.06.014
  • 7. Microtiter Plate-based Haemoglobin Estimation. Int J Lab Hematol. 2018 Apr; 40(2):196-200. doi: 10.1111/ijlh.12764. Epub 2017 Nov 21.
  • 8. Facility of Molecular Genotyping of blood group alleles/antigens at Surat Raktadan Kendra & Research Centre. Transfus Apher Sci. 2020 Feb;59(1):102599. doi: 10.1016/j.transci.2019.06.026.
  • 9. Verification of Surface Markers Expression and Pluripotency of Wharton’s jelly derived Mesenchymal Stem Cells (WJ-MSCs) by Molecular technique. Cell and Tissue Biology, 2021.
  • 10. MSCs are an attractive source of stem cells for clinical applications. These cells exhibit a multilineage differentiation potential and strong capacity for immune modulation. We have successfully established a method for isolation of MSCs from human umbilical cord (UC). This promising protocol is suitable for research applications of UC-MSCs moreover this established method will be appropriate for clinical applications of UCB-MSCs in the near future.

Members

Our institute is home to a distinguished faculty of stem cell biologists, developmental biologists, bioengineers, clinicians, and other experts who are leaders in their respective fields. Our faculty members are dedicated to conducting innovative research, mentoring the next generation of scientists, and translating research findings into clinical practice. Meet some of our esteemed faculty members:

Prof. Anjali Karande

Ph. D. Biochemistry

Tata Cancer Research Institute. Post-Doctoral Fellowship at Karolinska Institute, Stockholm, Sweden Professor, Indian Institute of Science (IISc), Bangalore (1987-2018)

Dr. Kanchan Mishra

Ph. D. SGPGIMS

Lucknow, Post Doctoral Fellowship –TMIN, Tokyo, Japan (2002-2005). Scientist: National Institute of Immunology (NII), Delhi, India (2006-2011),
-Vice President, Indian Stem Cell Study Group Association (ISCSG), (Since March 2024)
-Expert Member, Institutional Bio-safety Committee (IBSC), Arkray Healthcare Pvt. Ltd.
-Chairperson of Institutional Committee for stem cell research (IC-SCR) of Jai Research Foundation (JRF), Vapi, Gujarat, since 2021
-Chairperson of Institutional Committee for stem cell research IC-SCR-AIIMS Raipur, since 2023
-Adjunct Faculty, Faculty of Medicine, Datta Meghe Institute of Medical Sciences (DU), Wardha, Maharashtra. (March 2012 – March 2023)
-Secretary-General, Indian Stem Cell Study Group Association (ISCSG), (March 2019 – Feb 2024)
-Guest Faculty: Institute of Applied Science, Surat, Gujarat.
-Associate Editors: International Journal of Orthopaedic Rheumatology (IJORA),
-PUBLICATION: 48 published articles in national & international journals.

Dr. Rinku V. Shukla

B.SC., DMLT,MSc. Ph.D.

More than 15 years in Quality Control processes of Blood Centre.

Publications And Impact

Our researchers are prolific contributors to the academic literature, publishing their findings in top-tier journals and presenting their work at conferences around the world. Through their publications and scholarly activities, they have a significant impact on their respective fields, shaping the direction of research and influencing policy and practice. We are proud of the contributions our researchers make to the global academic community and the positive change they bring about through their work.Total Number of Published Papers is 111.

SRKRC-International Memorandum of Understanding (MOU)

The Trans European Stem Cell Therapy Society (TESCT)

was founded in 2005 by Dr. Marco Traub, in Switzerland to encourage the speedy transfer of stem cell technology from laboratory translation to clinical practice with the focus on the patient and the improvement of the life quality.

The Swiss Clinic

is a part of TESCT comprehensive health care facility providing the best of cell therapy and regenerative medicine to its clients

Samast Patidar Aarogya Trust

is a "NOT FOR PROFIT" Organization. The Trust has setup a State of the Art Multi Super specialty Kiran Hospital and Research Centre. The Hospital bridged qualitative lacuna in the sphere of Medicine, especially amongst the super speciality branches of modern Medical Science.

This healthcare facility is in the diamond capital of India, Surat, Gujarat,

SRKRC: Memorandum of Understanding (MOU)

Meril Bilakhia Group

Brings You World-Class Healthcare Solutions Founded in 2006, Meril is an India-based, global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices. As a leading healthcare solutions company, our fundamental aim is to champion the alleviation of human suffering and improve quality of life. To enable this, we are committed to R&D, innovation in manufacturing medical technology, scientific communication, and contemporary distribution avenues.